SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
beiu
Lv4
500 积分
2023-03-14 加入
最近求助
最近应助
互助留言
Targeting PI3Kα overcomes resistance to KRasG12C inhibitors mediated by activation of EGFR and/or IGF1R
9天前
已完结
Multiple initiatives to conquer KRAS G12C inhibitor resistance from the perspective of clinical therapy
9天前
已完结
Role of cGAS-STING in colorectal cancer: A new window for treatment strategies
1个月前
已完结
P1018: UPDATED RESULTS FROM MANIFEST ARM 2: EFFICACY AND SAFETY OF PELABRESIB (CPI-0610) AS ADD-ON TO RUXOLITINIB IN MYELOFIBROSIS
6个月前
已完结
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
6个月前
已完结
The KRAS crowd targets its next cancer mutations
7个月前
已完结
The KRAS crowd targets its next cancer mutations
7个月前
已完结
JDQ443, a Structurally Novel, Pyrazole-Based, Covalent Inhibitor of KRASG12C for the Treatment of Solid Tumors
8个月前
已完结
Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results
8个月前
已完结
A phase I/IB trial of binimetinib in combination with erlotinib in NSCLC harboring activating KRAS or EGFR mutations
8个月前
已完结
没有进行任何应助
感谢
9天前
感谢,点赞
1个月前
感谢
6个月前
感谢
8个月前
感谢
8个月前
感谢
8个月前
感谢
9个月前
感谢
9个月前
感谢
9个月前
感谢,点赞
9个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论